CLINICAL_TRIALS
trial_result
· 2021-11-23
Clinical Trial Update: Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus [Phase 2]
Summary
Phase 2 trial of a gastrin receptor antagonist in Barrett's Esophagus completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Columbia University | Conditions: Barrett's Esophagus | Phase 2 | Status: COMPLETED | Results posted: 2021-11-23